Maynard Um
-
-
-
-
-
-
-
Charles River and Medigen to use NGS for enterovirus vaccine work
-
-
-
-
-
-
-
Citi Adds Four Names to Catalyst Call List
-
-
-
-
-
-
-
FDA issues draft guidance to reduce animal testing for cancer drugs
-
-
-
-
-
-
-
RBC Capital Starts Charles River Labs (CRL) at Outperform, $215 PT
-
-
-
-
-
-
-
BofA Securities Upgrades Charles River Labs (CRL) to Buy
-
-
-
-
-
-
-
Charles River Labs plans divestitures, cost cuts following review
-
-
-
-
-
-
-
Charles River explores crowdfunding partnership with BioTech Social
-
466,312 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


